Research & Evidence

An older woman and clinician reviewing a daily-function worksheet in a bright consultation room

When Musculoskeletal Conditions Add Up: What a ...

A new prospective cohort study found that carrying multiple musculoskeletal conditions was associated with poorer quality of life and self-rated health over one year. The findings support a whole-person view—but...

When Musculoskeletal Conditions Add Up: What a ...

A new prospective cohort study found that carrying multiple musculoskeletal conditions was associated with poorer quality of life and self-rated health over one year. The findings support a whole-person view—but...

Older woman discussing cognitive health with a clinician in a warm consultation room

Cognitive Resilience: What Brain Immune Cells M...

A human brain-tissue study maps how microglia change between amyloid and tau pathology—and why some older adults may remain cognitively resilient despite substantial Alzheimer’s-related changes.

Cognitive Resilience: What Brain Immune Cells M...

A human brain-tissue study maps how microglia change between amyloid and tau pathology—and why some older adults may remain cognitively resilient despite substantial Alzheimer’s-related changes.

Dietitian discussing balanced protein foods and healthy aging with a middle-aged couple in a warm clinical setting

Valine and Healthy Aging: What a New Mouse Stud...

A new Nature Aging study found that lifelong valine restriction improved several measures of metabolic health in mice, while lifespan effects differed by sex. Here is what the research means—and...

Valine and Healthy Aging: What a New Mouse Stud...

A new Nature Aging study found that lifelong valine restriction improved several measures of metabolic health in mice, while lifespan effects differed by sex. Here is what the research means—and...

Clinician discussing an unbranded oral cholesterol medication with a middle-aged patient in a warm preventive-care setting

The First Oral PCSK9 Inhibitor: What the FDA Ap...

The FDA has approved the first once-daily oral PCSK9 inhibitor for adults who need additional LDL cholesterol reduction. Here is what the trials showed, why the tablet format matters, and...

The First Oral PCSK9 Inhibitor: What the FDA Ap...

The FDA has approved the first once-daily oral PCSK9 inhibitor for adults who need additional LDL cholesterol reduction. Here is what the trials showed, why the tablet format matters, and...

A mature woman and clinician review health research data together in a warm clinical setting

A New Window Into Cellular Aging: What Senescen...

A 2026 Cell Reports study found that blood-based protein signatures linked to specific senescent cell types tracked distinct dimensions of health and aging. Here is what the research means—and what...

A New Window Into Cellular Aging: What Senescen...

A 2026 Cell Reports study found that blood-based protein signatures linked to specific senescent cell types tracked distinct dimensions of health and aging. Here is what the research means—and what...

Peptides for Menopause: What the Evidence Supports and What Needs Caution

Peptides for Menopause: What the Evidence Suppo...

An educational review of peptides for menopause, including GLP-1s, PT-141, GHK-Cu, BPC-157, CJC-1295/ipamorelin, safety concerns, and why foundations come first.

Peptides for Menopause: What the Evidence Suppo...

An educational review of peptides for menopause, including GLP-1s, PT-141, GHK-Cu, BPC-157, CJC-1295/ipamorelin, safety concerns, and why foundations come first.